To include your compound in the COVID-19 Resource Center, submit it here.

Opening chromatin: long-term detriment?

Enhancing chromatin accessibility in cancer could be a liability, not a benefit

An Institute for Research in Biomedicine team has shown increasing chromatin accessibility in cancer could promote tumor aggressiveness, not reduce tumor mutation burden (TMB) as previously thought. The findings, reported last month in Nature Cell Biology, underscore the need to evaluate the long-term effects of chromatin

Read the full 464 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers